The Rockefeller University
Records under this name other than the patents The Rockefeller University holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 160 patents it holds.
Back to The Rockefeller University
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,541,385 | Chemically Modified Oligonucleotides for Use in Modulating Micro RNA and Uses Thereof now held by Regulus Therapeutics Inc. In force · High confidence | In force | High confidence | |
| US 8,298,781 | Compositions and Methods for Characterizing and Regulating Olfactory Sensation now held by Duke University In force · High confidence | In force | High confidence | |
| US 7,923,016 | Engineered CXCL 12 Alpha Locked Dimer Polypeptide now held by The Medical College of Wisconsin, Inc. In force · High confidence | In force | High confidence | |
| US 9,005,579 | Methods and Compositions for Enhanced Immunological Therapy and Targeting of Gram-Positive Bacteria now held by Contrafect Corporation In force · High confidence | In force | High confidence | |
| US 10,588,971 | Methods and Compositions for Enhanced Immunological Therapy and Targeting of Gram-Positive Bacteria now held by Contrafect Corporation In force · High confidence | In force | High confidence | |
| US 9,303,044 | 7-(Piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-ones for the Treatment of Thrombotic Disorders now held by The United States of America as Represented by the Secretary, Department of Health and Human Services In force · High confidence | In force | High confidence | |
| US 9,605,041 | Novel Regulatory Proteins and Inhibitors now held by Intra-Cellular Therapies, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 9,822,372 | CRISPR-Cas Component Systems, Methods and Compositions for Sequence Manipulation now held by Massachusetts Institute of Technology In force · Low confidence | In force | Low confidence | |
| US 9,002,472 | Neuromodulation Having Non-Linear Dynamics now held by Intelect Medical, Inc. In force · High confidence | In force | High confidence | |
| US 9,840,533 | Compositions and Methods for Altering Second Messenger Signaling now held by University of Bonn In force · High confidence | In force | High confidence |